STAT3 and lung cancer: Moreover, it was demonstrated that WT1 loss induced senescence and decreased proliferation of lung cancer cells downstream of oncogenic KRAS signalling [21].STAT3 is constitutively activated in many human tumors such as prostate, lung, brain, breast and pancreatic cancer [13], [15], [22], [23].